moa of semaglutide Mechanism absorption of oral semaglutide. SNAC indicates sodium Semaglutide Vs Tirzepatide For Weight

Semaglutide tends to be preferred for patients prioritizing the lower-cost option, patients who want the longer real-world safety track record (semaglutide has been on the market longer), and patients with insurance coverage that favors Wegovy or Ozempic

Maintain proper hydrationtissue repair processes require sufficient water

Safety / Side Effect Side effects recorded include irregular menstruation, anaphylaxis, edema, migraine headaches, and pregnancy (fertility increases)

Abstract The STEP 5 trial assessed the efficacy and safety of once-weekly subcutaneous semaglutide 2.4 mg versus placebo (both plus behavioral intervention) for long-term treatment of adults with obesity, or overweight with at least one weight-related comorbidity, without diabetes

Per the FDA label, if a patient has not lost at least 5% of baseline body weight after 12 weeks on the maintenance dose (2.4 mg), discontinuation should be considered